Peptide Characterization

Introduction The evolution of therapeutic peptides from research reagents to approved drugs over the past 50 years represents a major […]

Introduction Understanding the peptide characterization timeline is essential for pharmaceutical companies preparing an Investigational New Drug (IND) application or an

Introduction: Synthetic Peptide Impurity Analysis is the process of detecting, characterizing and controlling structurally similar impurities that remain after peptide

Introduction: Peptide Identity and Purity Testing is essential for determining whether a compounded or research-grade peptide is the correct molecule

Introduction: Immunogenicity Risk Assessment of Peptide Impurities is a key part of pharmaceutical development whenever an unexpected impurity appears in

Introduction: Peptide Synthesis vs Protein Manufacturing is an important distinction in pharmaceutical development, biotechnology, and analytical science, and the two

Introduction Peptide Analytical Method Development and Validation is a critical component of peptide drug development because peptide molecules present analytical

Introduction The comprehensive implementation of Oral Peptide Drug Product Characterization requires an integrated assessment of intestinal permeation enhancers, enzymatic degradation

Introduction Characterizing Peptides in PLGA Microsphere and Depot Formulations requires sophisticated orthogonal analytical methodologies to assess complex drug release kinetics,

Introduction The Immunogenicity Risk Assessment of Peptide Impurities represents a critical regulatory evaluation framework established by the U.S. Food and